Divalproex Sodium Tablet, Delayed Release
Product Images NDC 87441-028

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 87441-028). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Divalproex Sodium 250 mg (8744102701 Divalproex Sodium 250 mg)

Divalproex Sodium 250 mg (8744102701 Divalproex Sodium 250 mg)
Not available*
FDA Label Image

Divalproex Sodium 500 mg (8744102801 Divalproex Sodium 500 mg)

Divalproex Sodium 500 mg (8744102801 Divalproex Sodium 500 mg)
This is a description of Divalproex sodium tablets, USP, in 500 mg strength. It is a prescription-only medication used to treat certain conditions. The tablets are delayed-release and come with a Medication Guide to be given to each patient. The packaging meets USP standards for safety and quality. The product is distributed by Tuckahoe Enterprises, LL(, based in Henrico, VA.*
FDA Label Image

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 01)

FDA Label Image

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 02)

FDA Label Image

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 03)

FDA Label Image

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 04)

FDA Label Image

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 05)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.